1-3 of 3
Martha Rodriguez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Switching from Deferoxamine (Desferal ® , DFO) to Deferasirox (Exjade ® ) Maintains Effective Control of Iron Levels in Patients with Thalassemia Major (TM)

Maria Domenica Cappellini, Antonis Kattamis, Christos Kattamis, John B Porter, John M Ford, Martha Rodriguez, Lisa Rojkjaer, Antonio Piga
Journal: Blood
Blood (2008) 112 (11): 5416.
https://doi.org/10.1182/blood.V112.11.5416.5416
Published: 2008
Journal Articles

Deferasirox (Exjade ® ) in Pediatric Patients with β-Thalassemia: Update of 4.7-Year Efficacy and Safety from Extension Studies

Antonio Piga, Gian Luca Forni, Antonis Kattamis, Christos Kattamis, Yesim Aydinok, Martha Rodriguez, Lisa Rojkjaer, Renzo Galanello
Journal: Blood
Blood (2008) 112 (11): 3883.
https://doi.org/10.1182/blood.V112.11.3883.3883
Published: 2008
Journal Articles

Deferasirox (Exjade ® ), the Once-Daily Oral Iron Chelator, Demonstrates Safety and Efficacy in Patients with Sickle Cell Disease (SCD): 3.5-Year Follow-up.

Elliott Vichinsky, Thomas Coates, Alexis A Thompson, Françoise Bernaudin, Martha Rodriguez, Lisa Rojkjaer, Matthew M Heeney
Journal: Blood
Blood (2008) 112 (11): 1420.
https://doi.org/10.1182/blood.V112.11.1420.1420
Published: 2008